News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Company News

RainTree Oncology, Cardinal Health Specialty Solutions Sign Specialty Distribution and GPO Agreement

Dublin, OHIO – Jan. 27, 2015 – Cardinal Health Specialty Solutions today announced that it has signed a three-year agreement with RainTree Oncology Services to serve as its exclusive distributor for injectable, infused, oral oncolytic and supportive care specialty medications; and for Cardinal Health’s VitalSourceTM to serve as its group purchasing organization (GPO) for injectable and infused medications.

One of the nation’s leading community oncology alliances, RainTree Oncology Services assists its member practices in achieving effective and cost-efficient treatment of oncology patients and in creating new streams of revenue.

“We are committed to providing RainTree Oncology members with the specialty distribution, technology, and support services its members need to continue to run successful, efficient businesses that provide patients with access to quality, convenient cancer care,” said Mike Mullen, general manager of Specialty Distribution for Cardinal Health Specialty Solutions. “The response to this new agreement has been extremely positive, and we are excited to already be working with 15 of RainTree Oncology’s member practices.”

Along with specialty distribution services, RainTree Oncology members will have access to Cardinal Health Specialty Solutions’ leading edge, Web-based practice management solutions to help optimize their businesses and improve operational efficiency.  These include:

Remittance and Claims Manager, a proprietary claims management tool that helps practices improve cash flow and revenues;

Inventory Management Solution, an automated medication dispensing system designed to make it easier for practices to improve patient safety, inventory and revenue management;

Advanced Practice Analytics, a dynamic reporting suite that combines operational, clinical and financial data into customizable and meaningful reports to enable practices to make informed decisions at the touch of a button; and

PathWare™, a Pathways Management Solution, which provides access to evidence-based treatment regimens to make it easier for practices to manage multiple payer pathways programs and enhance practice efficiencies while improving the quality and reducing the cost of caring for patients with complex diseases.

“We chose to partner with Cardinal Health Specialty Solutions because of their dedication to supporting the growth of community oncology, and because of their robust set of tools that can positively impact our practice members,” said Mike Martin, CEO of RainTree Oncology Services.

Dr. Jeff Patton, CEO of Tennessee Oncology (a member of RainTree Oncology) added; “Cardinal Health has been a true partner throughout the transition process.  We have already begun to enjoy the benefits of Cardinal Health’s technology platform as well as their excellent customer service.  Both enable us to help patients more efficiently.”

Bruce Gould, MD, medical director of Northwest Georgia Oncology Centers, P.C. (also a member of RainTree Oncology), added that his practice’s partnership with Cardinal Health is critical to its mission of providing community-based, patient-centered care.

About RainTree Oncology Services
RainTree Oncology Services is the nation’s leading community oncology alliance, assisting more than 30 member practices in achieving better and more cost-effective treatment of oncology patients while creating new streams of revenue for community oncology practices. RainTree Oncology achieves this by negotiating and administering favorable GPO contracts; by implementing technology allowing RainTree Oncology members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the healthcare system; and by developing commercial relationships that accelerate innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology. For more information, visit or

About Cardinal Health Specialty Solutions
Cardinal Health Specialty Solutions provides regulatory, clinical, reimbursement, technology and distribution services to help health care professionals, payors and pharmaceutical and biotech companies improve the quality and cost-effectiveness of caring for patients who are managing complex diseases.  Cardinal Health Specialty Solutions partners with customers to alleviate day-to-day administrative burdens, optimize business functions and to implement new innovations that move their businesses forward.  To learn more, visit

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals, medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies, which dispense products to aid in the early diagnosis and treatment of disease. Ranked #22 on the Fortune 500, Cardinal Health employs more than 34,000 people worldwide. More information about the company may be found at and @CardinalHealth on Twitter.


More Company News

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health


Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...


Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields